TeraRecon Announces Launch of its Next Generation Eureka Clinical AI Platform
CAMBRIDGE, Mass., Oct. 20, 2022 /PRNewswire/ -- TeraRecon, an industry leader in advanced visualization and artificial intelligence (AI) for medical imaging, announced the launch of its next-generation Eureka Clinical AI platform. Designed to support the communication infrastructure and enable collaboration for the entire care team, the platform serves as an end-to-end clinical application integrating multiple AI algorithms and workflows. Eureka Clinical AI supports dual desktop and mobile viewers for cross-specialty collaboration and patient-specific sharing of AI results to accelerate timely access to mission critical images and insights.
- The Eureka Clinical AI platform is unique in supporting third-party, customer-developed, and TeraRecon-developed AI algorithms in one unified workflow with clear model-management capabilities.
- The Eureka Clinical AI platform is supplemented by TR Analytics, providing critical insights to monitor productivity and platform utilization, individual AI algorithm performance.
- "We are excited with the Eureka Clinical AI platform and its capabilities in executing 3rd party AI algorithms, such as InferVision's InferRead CT Lung AI.
- With the launch of the Eureka Clinical AI platform, TeraRecon expands into the AI platform market furthering its mission to deliver AI powered solutions that improve outcomes, streamline workflows and reduce burnout for clinicians.